S Mullick1, M Beksinksa, S Msomi. 1. Population Council, Frontiers in Reproductive Health, Hyde Park Lane Manor, EG001 Edinburgh Gate, Hyde Park, Box 411744, Craighall 2024, Johannesburg, South Africa. smullick@pcjoburg.org.za
Abstract
BACKGROUND: In South Africa, three doses of benzathine penicillin 2.4 MU at weekly intervals are recommended for treating syphilis in pregnancy. Limited information is available on compliance with the recommended regimen, in terms of time to starting treatment, number of doses, and timing of treatment. METHODS: The study was conducted to establish the degree of compliance with treatment for syphilis. Timing of treatment and the titres of the rapid plasma reagin (RPR) positive women were recorded. A retrospective record review was conducted of 18,128 antenatal records. These were records of women attending antenatal care clinics in a tertiary hospital catchment area in KwaZulu Natal between February 2001 and January 2002. RESULTS: Treatment patterns showed that 15.9% received no treatment, 13.2% one dose, 5.8% received two doses, and 64.8% received three doses. In total, 188 women (1.03%) were found to be RPR positive. Of these 36% were found to be high titre positives (titre > or = 1:8). CONCLUSION: Completed treatment was significantly associated with age of gestation at first visit (p = 0.029), with women attending later in pregnancy less likely to receive all three doses of treatment.
BACKGROUND: In South Africa, three doses of benzathine penicillin 2.4 MU at weekly intervals are recommended for treating syphilis in pregnancy. Limited information is available on compliance with the recommended regimen, in terms of time to starting treatment, number of doses, and timing of treatment. METHODS: The study was conducted to establish the degree of compliance with treatment for syphilis. Timing of treatment and the titres of the rapid plasma reagin (RPR) positive women were recorded. A retrospective record review was conducted of 18,128 antenatal records. These were records of women attending antenatal care clinics in a tertiary hospital catchment area in KwaZulu Natal between February 2001 and January 2002. RESULTS: Treatment patterns showed that 15.9% received no treatment, 13.2% one dose, 5.8% received two doses, and 64.8% received three doses. In total, 188 women (1.03%) were found to be RPR positive. Of these 36% were found to be high titre positives (titre > or = 1:8). CONCLUSION: Completed treatment was significantly associated with age of gestation at first visit (p = 0.029), with women attending later in pregnancy less likely to receive all three doses of treatment.
Authors: Deborah Watson-Jones; Balthazar Gumodoka; Helen Weiss; John Changalucha; James Todd; Kokungoza Mugeye; Anne Buvé; Zephrine Kanga; Leonard Ndeki; Mary Rusizoka; David Ross; Janeth Marealle; Rebecca Balira; David Mabey; Richard Hayes Journal: J Infect Dis Date: 2002-09-03 Impact factor: 5.226
Authors: Saiqa Mullick; Nathalie Broutet; Ye Htun; Marleen Temmerman; Francis Ndowa Journal: Bull World Health Organ Date: 2004-06 Impact factor: 9.408
Authors: M Temmerman; P Gichangi; K Fonck; L Apers; P Claeys; L Van Renterghem; D Kiragu; G Karanja; J Ndinya-Achola; J Bwayo Journal: Sex Transm Infect Date: 2000-04 Impact factor: 3.519
Authors: Tais F Galvao; Marcus T Silva; Suzanne J Serruya; Lori M Newman; Jeffrey D Klausner; Mauricio G Pereira; Ricardo Fescina Journal: PLoS One Date: 2013-02-21 Impact factor: 3.240